AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 170 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 8.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $2,105,000 | +4.5% | 223,935 | -14.9% | 0.00% | 0.0% |
| Q2 2020 | $2,014,000 | +24.2% | 263,224 | +0.4% | 0.00% | 0.0% |
| Q1 2020 | $1,621,000 | -51.2% | 262,262 | -3.9% | 0.00% | -33.3% |
| Q4 2019 | $3,321,000 | +5.5% | 272,905 | +0.1% | 0.00% | 0.0% |
| Q3 2019 | $3,148,000 | +14.1% | 272,539 | -1.3% | 0.00% | +50.0% |
| Q2 2019 | $2,759,000 | -24.6% | 276,135 | -2.8% | 0.00% | -33.3% |
| Q1 2019 | $3,659,000 | -15.6% | 284,051 | -0.4% | 0.00% | -40.0% |
| Q4 2018 | $4,334,000 | -23.6% | 285,332 | +0.6% | 0.01% | 0.0% |
| Q3 2018 | $5,674,000 | +6.7% | 283,719 | +4.1% | 0.01% | 0.0% |
| Q2 2018 | $5,316,000 | -1.4% | 272,623 | +1.9% | 0.01% | 0.0% |
| Q1 2018 | $5,393,000 | +50.5% | 267,631 | -1.0% | 0.01% | +66.7% |
| Q4 2017 | $3,584,000 | -27.3% | 270,462 | +1.2% | 0.00% | -40.0% |
| Q3 2017 | $4,928,000 | +0.1% | 267,124 | -0.2% | 0.01% | 0.0% |
| Q2 2017 | $4,923,000 | -16.6% | 267,561 | +2.2% | 0.01% | -28.6% |
| Q1 2017 | $5,906,000 | -34.2% | 261,929 | +1.6% | 0.01% | -36.4% |
| Q4 2016 | $8,976,000 | +47.6% | 257,921 | +3.9% | 0.01% | +37.5% |
| Q3 2016 | $6,083,000 | -8.2% | 248,199 | -10.4% | 0.01% | -11.1% |
| Q2 2016 | $6,624,000 | +4.0% | 276,923 | +1.8% | 0.01% | 0.0% |
| Q1 2016 | $6,368,000 | +515.9% | 272,150 | +693.9% | 0.01% | +350.0% |
| Q4 2015 | $1,034,000 | +28.4% | 34,282 | +69.2% | 0.00% | +100.0% |
| Q3 2015 | $805,000 | +121.2% | 20,265 | +285.0% | 0.00% | 0.0% |
| Q2 2015 | $364,000 | +4.6% | 5,264 | -17.5% | 0.00% | 0.0% |
| Q1 2015 | $348,000 | +35.4% | 6,379 | +5.7% | 0.00% | – |
| Q4 2014 | $257,000 | +27.2% | 6,037 | -42.1% | 0.00% | – |
| Q1 2014 | $202,000 | -21.1% | 10,429 | -0.9% | 0.00% | – |
| Q4 2013 | $256,000 | +13.3% | 10,528 | 0.0% | 0.00% | – |
| Q3 2013 | $226,000 | -9.6% | 10,528 | -6.2% | 0.00% | -100.0% |
| Q2 2013 | $250,000 | – | 11,218 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $14 | 0.00% |